Skip to main content
Fig. 3 | Arthritis Research & Therapy

Fig. 3

From: Efficient delivery of the lncRNA LEF1-AS1 through the antibody LAIR-1 (CD305)-modified Zn-Adenine targets articular inflammation to enhance the treatment of rheumatoid arthritis

Fig. 3

Synthesis and characterization of Zn-Adenine and (Zn-Adenine)@Ab. A Immunoblot showing relative expression of CD305 protein in normal or rheumatoid synovial tissue and cells (n = 5 in triplicate). B SEM images of Zn-Adenine and (Zn-Adenine)@Ab. C The FT-IR spectrum of Zn-Adenine and (Zn-Adenine)@Ab. D DLS was used to measure the particle size of Zn-Adenine (upper graph) and (Zn-Adenine)@Ab (lower graph)

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us